Mark J Enyedy - Net Worth and Insider Trading
Mark J Enyedy Net Worth
The estimated net worth of Mark J Enyedy is at least $18 Million dollars as of 2024-11-29. Mark J Enyedy is the CHIEF EXECUTIVE OFFICER of Immunogen Inc and owns about 584,397 shares of Immunogen Inc (IMGN) stock worth over $18 Million. Details can be seen in Mark J Enyedy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark J Enyedy has not made any transactions after 2024-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark J Enyedy
Mark J Enyedy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark J Enyedy owns 5 companies in total, including Immunogen Inc (IMGN) , LogicBio Therapeutics Inc (LOGC) , and Akebia Therapeutics Inc (AKBA) among others .
Click here to see the complete history of Mark J Enyedy’s form 4 insider trades.
Insider Ownership Summary of Mark J Enyedy
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IMGN | Immunogen Inc | 2024-02-05 | director & Chief Executive Officer |
LOGC | LogicBio Therapeutics Inc | 2022-11-16 | director |
AKBA | Akebia Therapeutics Inc | 2018-12-12 | director |
2018-12-12 | director | ||
2013-09-30 | director |
Mark J Enyedy Latest Holdings Summary
Mark J Enyedy currently owns a total of 1 stock. Mark J Enyedy owns 584,397 shares of Immunogen Inc (IMGN) as of February 5, 2024, with a value of $18 Million.
Latest Holdings of Mark J Enyedy
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
IMGN | Immunogen Inc | 2024-02-05 | 584,397 | 31.23 | 18,250,718 |
Holding Weightings of Mark J Enyedy
Mark J Enyedy Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark J Enyedy has made a total of 3 transactions in Immunogen Inc (IMGN) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Immunogen Inc is the sale of 20,107 shares on February 5, 2024, which brought Mark J Enyedy around $588,733.
Insider Trading History of Mark J Enyedy
- 1
Mark J Enyedy Trading Performance
GuruFocus tracks the stock performance after each of Mark J Enyedy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark J Enyedy is 31.28%. GuruFocus also compares Mark J Enyedy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark J Enyedy within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark J Enyedy's insider trading performs compared to the benchmark.
Performance of Mark J Enyedy
Mark J Enyedy Ownership Network
Mark J Enyedy Owned Company Details
What does Immunogen Inc do?
Who are the key executives at Immunogen Inc?
Mark J Enyedy is the director & Chief Executive Officer of Immunogen Inc. Other key executives at Immunogen Inc include Chief Business Officer Stacy Ann Coen , V.P.-Fin. & Prin. Acctg. Off. Renee Lentini , and VP of Regulatory Affairs Theresa Wingrove .
Immunogen Inc (IMGN) Insider Trades Summary
Over the past 18 months, Mark J Enyedy made 2 insider transaction in Immunogen Inc (IMGN) with a net sale of 3,027,661. Other recent insider transactions involving Immunogen Inc (IMGN) include a net sale of 1,058,614 shares made by Theresa Wingrove , a net sale of 301,809 shares made by Stacy Ann Coen , and a net sale of 377,001 shares made by Renee Lentini .
In summary, during the past 3 months, insiders sold 0 shares of Immunogen Inc (IMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,785,085 shares of Immunogen Inc (IMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,785,085 shares.
Immunogen Inc (IMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunogen Inc Insider Transactions
Mark J Enyedy Mailing Address
Above is the net worth, insider trading, and ownership report for Mark J Enyedy. You might contact Mark J Enyedy via mailing address: C/o Fate Therapeutics, Inc., 3535 General Atomics Court, Suite 200, San Diego Ca 92121.